Piramal Pharma (PPLPHARMA.NSE) Q2 2026 Earnings

28AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.81
-0.1
0.61
1.32

Details

Expected EPS
0.9715625582399999
Actual EPS
1.31565763095
Surprise EPS
0.34
Surprise Percent
+35.42%

Description

Piramal Pharma (PPLPHARMA.NSE) has reported earnings of 1.31565763095 per share for Q2 2026.

0 Comments

Share your thoughts